Skip to main content

Table 2 Laboratory findings of patients with COVID-19 on admission to hospital

From: Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19

 

Normal range

Mild cases (N = 89)

Severe cases (N = 62)

P

White blood cell count, × 109/L

3.5–9.5

4.9 (2.0)

7.3 (6.7)

0.000

Neutrophil count, × 109/L

1.8–6.3

3.0 (2.1)

5.8 (7.1)

0.000

Lymphocyte count, × 109/L

1.1–3.2

1.2 ± 0.5

0.8 ± 0.4

0.000

Alanine aminotransferase, U/L

≤ 33

28 ± 32

34 ± 27

0.266

Aspartate aminotransferase, U/L

≤ 32

24.0 (13.0)

36.0 (26.0)

0.000

Lactate dehydrogenase, U/L

135–214

251.0 (93.0)

431.5 (367.0)

0.000

Creatinine, μmol/L

45–84

70.0 (28.5)

81.5 (33.0)

0.003

Uric acid, μmol/L

202.3–416.6

248.0 (103.9)

264.5 (168.9)

0.036

Total cholesterol, mmol/L

< 5.18

3.8 ± 0.7

3.6 ± 0.8

0.089

C-reactive protein, mg/L

< 1

12.6 (36.4)

68.7 (114.6)

0.000

Erythrocyte sedimentation rate, mm/H

0–20

28 ± 22

32 ± 22

0.477

Ferritin, ug/L

15–150

888.2 ± 2181.7

1869.1 ± 2229.4

0.027

TNFα, pg/mL

< 8.1

7.3 (3.3)

9.1 (6.0)

0.002

HbA1c,  %

4–6

6.0 ± 1.5

6.7 ± 2.1

0.083

Fasting glucose, mmol/L

4.11–6.55

6.2 (2.3)

8.4 (5.8)

0.000

Triglyceride, mmol/L

< 1.7

1.4 ± 1.0

1.5 ± 0.6

0.431

TyG

8.7 ± 0.6

9.2 ± 0.6

0.000

  1. Continuous data were expressed as mean ± SD or median (interquartile range)
  2. P values indicate differences between mild and severe cases. P < 0.05 was considered statistically significant